Combined use of ribavirin and interferon beta in demyelinating diseases

Details for Australian Patent Application No. 2004216485 (hide)

International Classifications

Event Publications

11 August 2005 PCT application entered the National Phase

PCT publication WO2004/075903 Priority application(s): WO2004/075903

25 October 2007 Assignment before Grant

Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA Assignments before Grant, Section 113

30 April 2009 Alteration of Name

The name of the applicant has been altered to Merck Serono SA

11 June 2009 Application Accepted

Published as AU-B-2004216485

8 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.